Step Two Corp. (531509)

Score breakdown: P/E: 2/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Reported ROE of 32.14% is high, indicating decent return on equity from a small capital base
• P/E of 12.11 is not optically expensive if current earnings are sustainable
• Piotroski F-Score of 6/9 suggests moderate financial health and no immediate distress
• Price is near the upper end of its 52-week range, showing recent market interest

Concerns

• Sales growth and profit growth are both 0.00%, with latest quarter net profit at ₹0 Cr
• P/B of 5.63 against book value of ₹6.42 leaves no margin of safety for a value investor
• ROCE of -0.53% contradicts the high ROE, suggesting weak underlying operating returns
• Zero dividend yield and no promoter holding details raise transparency and minority-interest concerns

AI Analysis

When I look at Step Two Corp., the first thing that strikes me is the contradiction. A reported ROE of 32.14% sounds impressive, but ROCE is -0.53%. That tells me the business itself isn't earning a decent return on capital employed; the high return on equity may be an artefact of a tiny equity base or financial leverage, not an underlying moat. With sales of just ₹1 Cr in the latest quarter and net profit of ₹0 Cr, this is a micro-cap that has not proven it can generate consistent earnings power. Sales growth and profit growth are both 0.00%, so there is no evidence of a growth engine. The P/E of 12.11 looks cheap at first glance, but Graham would ask: cheap relative to what? Book value is ₹6.42, yet the market price is ₹36.15 — that's 5.63 times book. For a company with zero growth, zero dividend, and no promoter holding details, paying 5.6 times book offers no margin of safety. The Piotroski F-Score of 6/9 suggests moderate financial health, but it is not a glowing endorsement. The PEG ratio of 0.03 is suspicious — with no profit growth, any PEG-based valuation is meaningless. This is a very small company, market cap only ₹16 Cr, so liquidity and corporate governance risks are real. I cannot build a position based on hope. I need predictable earnings, a durable competitive advantage, and a reasonable price. Step Two Corp. has none of these in clear evidence. It may be an interesting trading stock for speculators, not an investment for the patient value investor. I'd keep it on the watchlist, but only if it later shows real earnings growth, better capital allocation, and a price closer to book value.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer